Analysts consider AtaiBeckley’s MDMA candidate a “high-risk, high-reward” bet after the drug demonstrated reductions in anxiety severity in a phase 2a study. AtaiBeckley—the new name for atai Life ...
This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). A U.S. Food and Drug ...
MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...
The Food and Drug Administration on Friday rejected a California drug company's request to market the psychedelic drug MDMA combined with talk therapy as a treatment for post-traumatic stress disorder ...
The Food and Drug Administration's panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder ...
WASHINGTON — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. Lief Fenno, chair of the American Psychiatric Association Council on Addiction Psychiatry, says it's hard to get exact data on ...
Rick Doblin first dreamed of the therapeutic potential of the psychedelic drug MDMA in a hippie house in downtown Santa Cruz, in an era when fears of bad trips and ruined lives loomed large in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results